145 related articles for article (PubMed ID: 35896851)
1. A prognostic survival model for women diagnosed with invasive breast cancer in Queensland, Australia.
Baade PD; Fowler H; Kou K; Dunn J; Chambers SK; Pyke C; Aitken JF
Breast Cancer Res Treat; 2022 Sep; 195(2):191-200. PubMed ID: 35896851
[TBL] [Abstract][Full Text] [Related]
2. Individual and area level factors associated with the breast cancer diagnostic-treatment interval in Queensland, Australia.
Retell JD; Cameron JK; Aitken JF; Youl P; Pyke C; Dunn J; Chambers S; Baade PD
Breast Cancer Res Treat; 2024 Feb; 203(3):575-586. PubMed ID: 37930491
[TBL] [Abstract][Full Text] [Related]
3. Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study.
Kou K; Cameron J; Youl P; Pyke C; Chambers S; Dunn J; Aitken JF; Baade PD
Breast Cancer; 2023 May; 30(3):466-477. PubMed ID: 36809492
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with being diagnosed with high severity of breast cancer: a population-based study in Queensland, Australia.
Kou K; Cameron J; Aitken JF; Youl P; Turrell G; Chambers S; Dunn J; Pyke C; Baade PD
Breast Cancer Res Treat; 2020 Dec; 184(3):937-950. PubMed ID: 32926317
[TBL] [Abstract][Full Text] [Related]
5. Treatment intervals and survival for women diagnosed with early breast cancer in Queensland: the Breast Cancer Outcomes Study, a population-based cohort study.
Kou K; Aitken JF; Pyke C; Chambers S; Dunn J; Baade PD
Med J Aust; 2023 Nov; 219(9):409-416. PubMed ID: 37667512
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Incidence and Survival Among Young Females in Queensland, Australia.
Youlden DR; Baade PD; Walker R; Pyke CM; Roder DM; Aitken JF
J Adolesc Young Adult Oncol; 2020 Jun; 9(3):402-409. PubMed ID: 31765264
[No Abstract] [Full Text] [Related]
7. Breast-cancer mortality in screened versus unscreened women: Long-term results from a population-based study in Queensland, Australia.
Dunn N; Youl P; Moore J; Harden H; Walpole E; Evans E; Taylor K; Philpot S; Furnival C
J Med Screen; 2021 Jun; 28(2):193-199. PubMed ID: 32842857
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
11. Development of a key performance indicator for breast cancer in Queensland, Australia.
Walpole ET; Youl PH; Moore J; Morris M; Cossio D; Dhanda P; Theile DE; Philpot S
Breast Cancer Res Treat; 2023 Jan; 197(1):211-221. PubMed ID: 36350472
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
[TBL] [Abstract][Full Text] [Related]
13. Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45-69 years in Queensland, Australia.
Wilson LF; Page AN; Dunn NA; Pandeya N; Protani MM; Taylor RJ
Maturitas; 2013 Dec; 76(4):370-6. PubMed ID: 24113278
[TBL] [Abstract][Full Text] [Related]
14. Geographic variation in the intended choice of adjuvant treatments for women diagnosed with screen-detected breast cancer in Queensland.
Hsieh JC; Cramb SM; McGree JM; Dunn NA; Baade PD; Mengersen KL
BMC Public Health; 2015 Dec; 15():1204. PubMed ID: 26630881
[TBL] [Abstract][Full Text] [Related]
15. Screening status, tumour subtype, and breast cancer survival: a national population-based analysis.
O'Brien KM; Mooney T; Fitzpatrick P; Sharp L
Breast Cancer Res Treat; 2018 Nov; 172(1):133-142. PubMed ID: 30006795
[TBL] [Abstract][Full Text] [Related]
16. Quantifying the Costs to Different Funders over Five-Years for Women Diagnosed with Breast Cancer in Queensland, Australia: A Data Linkage Study.
Lindsay D; Callander E
Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948528
[TBL] [Abstract][Full Text] [Related]
17. Trends in surgery and adjuvant treatment for early-stage breast cancer: a population-based study in Queensland, Australia.
Youl P; Philpot S; Moore J; Morris M; Theile DE
Breast Cancer Res Treat; 2022 May; 193(1):175-185. PubMed ID: 35254604
[TBL] [Abstract][Full Text] [Related]
18. Competing mortality risks among women aged 50-79 years when diagnosed with invasive breast cancer, Queensland, 1997-2012.
Dasgupta P; Aitken JF; Pyke C; Baade PD
Breast; 2018 Oct; 41():113-119. PubMed ID: 30029053
[TBL] [Abstract][Full Text] [Related]
19. Quantifying the hospital and emergency department costs for women diagnosed with breast cancer in Queensland.
Lindsay D; Bates N; Diaz A; Watt K; Callander E
Support Care Cancer; 2022 Mar; 30(3):2141-2150. PubMed ID: 34676449
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
